tiprankstipranks
Trending News
More News >
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
Advertisement

Oncotelic Therapeutics (OTLC) Stock News & Sentiment

Compare
82 Followers
Oncotelic Therapeutics Delays Yearly Report Filing
Premium
Company Announcements
Oncotelic Therapeutics Delays Yearly Report Filing
4M ago
Oncotelic Therapeutics ( ($OTLC) ) has released a notification of late filing. Oncotelic Therapeutics, Inc. has filed a Form 12b-25, indicating a delay in submitting its Form 10-K (Yearly Report) ...Read more
Oncotelic Therapeutics Secures Funds Through Equity Sales
Premium
Company Announcements
Oncotelic Therapeutics Secures Funds Through Equity Sales
1y ago
Oncotelic Therapeutics Strikes Material Definitive Legal Agreement
Premium
Company Announcements
Oncotelic Therapeutics Strikes Material Definitive Legal Agreement
1y ago

News Score - Last 7 Days

Neutral
OTLC
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OTLC’s Media Buzz Sentiment?
Currently, no data Available
What is OTLC’s weekly average amount of articles?
Currently, no data Available
What is OTLC’s News Sentiment?
50% of articles about OTLC were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    IXIIXICO plc
    GMABGenmab
    THCTenet Healthcare
    ICCCImmucell
    SRPTSarepta Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis